首页> 外文会议>International Conference on Medical and Biological Engineering >Prostate Tissue Classification Based on Prostate-Specific Antigen Levels and Mitochondrial DNA Copy Number Using Artificial Neural Network
【24h】

Prostate Tissue Classification Based on Prostate-Specific Antigen Levels and Mitochondrial DNA Copy Number Using Artificial Neural Network

机译:基于前列腺特异性抗原水平和使用人工神经网络的线粒体DNA拷贝数的前列腺组织分类

获取原文

摘要

Prostate cancer is the most prominent cancer in men and one of the leading morbidity causes when referred to cancer. Prostate cancer usually affects men older than 65 but young men can also acquire cancer in specific conditions. Over the years, vast amounts of data about Prostate-Specific Antigen (PSA) levels were collected and together with novel mitochondrial DNA (mtDNA) copy number data can be used for risk assessment and prostate cancer diagnosis. This paper presents development of an Artificial Neural network (ANN) for classification between normal and prostate cancer patients based upon Prostate- Specific Antigen (PSA) levels and Mitochondrial DNA (mtDNA) copy number. For the development of Neural Network, samples of PSA level and mtDNA copy number were used. State of prostate was classified based on 352 samples as normal or cancerous with 175 samples being normal according to biopsy results and 177 being cancerous according to biopsy results. Among all tested architectures, the two4ayer feedforward ANN with Logsig transfer function showed the best performance. An addition of k-fold cross validation method yielded better results with sensitivity was 100%, specificity 98.8% and overall accuracy of the system in subsequent validation was 99.4%.
机译:前列腺癌是男性中最突出的癌症和引用癌症时的主要发病率之一。前列腺癌通常影响超过65岁的男性,但年轻人也可以在特定条件下获得癌症。多年来,收集了关于前列腺特异性抗原(PSA)水平的大量数据,并与新型线粒体DNA(MTDNA)拷贝数数据一起用于风险评估和前列腺癌诊断。本文介绍了基于前列腺特异性抗原(PSA)水平和线粒体DNA(MTDNA)拷贝数的正常和前列腺癌患者分类的人工神经网络(ANN)的发展。为了开发神经网络,使用PSA水平和MTDNA拷贝数的样本。前列腺状态基于352个样品作为正常或癌症的样本,根据活组织检查结果,175个样品是正常的,并且根据活组织检查结果,癌症是癌症的。在所有测试的架构中,具有Logsig传递函数的两个4EER前馈ANN显示出最佳性能。添加k折交叉验证方法,敏感性效果更好,敏感性为100%,特异性98.8%,系统随后验证的总体精度为99.4%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号